DE69611598D1 - Azoderivate von 5-aminosalicylsäure zur behandlung von enzündlichen darmerkrankungen - Google Patents

Azoderivate von 5-aminosalicylsäure zur behandlung von enzündlichen darmerkrankungen

Info

Publication number
DE69611598D1
DE69611598D1 DE69611598T DE69611598T DE69611598D1 DE 69611598 D1 DE69611598 D1 DE 69611598D1 DE 69611598 T DE69611598 T DE 69611598T DE 69611598 T DE69611598 T DE 69611598T DE 69611598 D1 DE69611598 D1 DE 69611598D1
Authority
DE
Germany
Prior art keywords
azoderivates
inflammable
treatment
aminosalicylic acid
colon diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69611598T
Other languages
English (en)
Other versions
DE69611598T2 (de
Inventor
Elena Carceller
Pere J Jimenez
Jordi Salas
Carmen Almansa
Javier Bartroli
Manel Merlos
Marta Giral
Dolors Balsa
Rosa Ferrando
Julian Garcia-Rafanell
Javier Forn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Palau Pharma SA
Original Assignee
J Uriach y Cia SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES9501752A external-priority patent/ES2106682B1/es
Priority claimed from ES9501967A external-priority patent/ES2104513B1/es
Application filed by J Uriach y Cia SA filed Critical J Uriach y Cia SA
Publication of DE69611598D1 publication Critical patent/DE69611598D1/de
Application granted granted Critical
Publication of DE69611598T2 publication Critical patent/DE69611598T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69611598T 1995-09-08 1996-09-06 Azoderivate von 5-aminosalicylsäure zur behandlung von enzündlichen darmerkrankungen Expired - Lifetime DE69611598T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES9501752A ES2106682B1 (es) 1995-09-08 1995-09-08 Nuevos derivados azo del acido 5-aminosalicilico.
ES9501967A ES2104513B1 (es) 1995-10-11 1995-10-11 Nuevos derivados del acido 5-aminosalicilico.
PCT/EP1996/003921 WO1997009329A1 (en) 1995-09-08 1996-09-06 Azo derivatives of 5-aminosalicylic acid for treatment of inflammatory bowel disease

Publications (2)

Publication Number Publication Date
DE69611598D1 true DE69611598D1 (de) 2001-02-22
DE69611598T2 DE69611598T2 (de) 2001-06-07

Family

ID=26154915

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69611598T Expired - Lifetime DE69611598T2 (de) 1995-09-08 1996-09-06 Azoderivate von 5-aminosalicylsäure zur behandlung von enzündlichen darmerkrankungen

Country Status (17)

Country Link
US (1) US5747477A (de)
EP (1) EP0790998B1 (de)
JP (1) JP4115522B2 (de)
KR (1) KR100481300B1 (de)
AR (1) AR004198A1 (de)
AT (1) ATE198751T1 (de)
AU (1) AU6987596A (de)
BR (1) BR9606628A (de)
CA (1) CA2204747C (de)
DE (1) DE69611598T2 (de)
DK (1) DK0790998T3 (de)
ES (1) ES2155621T3 (de)
GR (1) GR3035622T3 (de)
MX (1) MX9702919A (de)
NO (1) NO308850B1 (de)
PT (1) PT790998E (de)
WO (1) WO1997009329A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958324B2 (en) * 1998-12-02 2005-10-25 Inotek Pharmaceuticals Corporation Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
ES2165803B1 (es) 2000-04-10 2003-09-16 Uriach & Cia Sa J Nueva sal de un derivado azo del acido 5-aminosalicilico
US6638950B2 (en) 2000-06-21 2003-10-28 Bristol-Myers Squibb Pharma Company Piperidine amides as modulators of chemokine receptor activity
TWI249519B (en) 2000-08-29 2006-02-21 Nobex Corp Immunoregulatory compounds and derivatives and methods of treating diseases therewith
US8048924B2 (en) * 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
US20030119792A1 (en) * 2001-09-28 2003-06-26 Roca Manuel Merlos Method of inhibiting the production and/or effects of intestinal pro-inflammatory cytokines, prostaglandins and others
HUE028158T2 (en) 2004-07-07 2016-12-28 Biocon Ltd Synthesis of bound immunoregulatory compounds
WO2006125293A1 (en) 2005-05-27 2006-11-30 Antibe Therapeutics Inc. Derivatives of 4- or 5-aminosalicylic acid
US7741359B2 (en) 2005-05-27 2010-06-22 Antibe Therapeutics Inc. Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
US7498355B2 (en) 2005-05-27 2009-03-03 Antibe Therapeutics Inc. Derivatives of 4- or 5-aminosalicylic acid
US7666907B2 (en) 2005-05-27 2010-02-23 Antibe Therapeutics Inc. Salts of trimebutine and N-desmethyl trimebutine
US7645801B2 (en) 2007-01-29 2010-01-12 Alaven Pharmaceutical Llc Reduced irritant enema for treatment of inflammatory bowel disease (IBD)
CN105566153B (zh) * 2014-10-14 2019-05-31 中国医学科学院药物研究所 偶氮苯衍生物及其制法和药物组合物与用途
KR102173168B1 (ko) 2018-06-19 2020-11-03 주식회사 엠디헬스케어 류코노스톡속 균주를 포함하는 장 기능 개선용 조성물
WO2019245225A1 (ko) 2018-06-19 2019-12-26 (주)코엔바이오 류코노스톡속 균주를 포함하는 장 기능 개선용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2396145A (en) * 1940-12-14 1946-03-05 Pharmscia Ab Heterocyclic sulphonamido azo compounds
US4312806A (en) * 1981-03-02 1982-01-26 G. D. Searle & Co. Method and compounds for treating inflammatory bowel disease
PT98673B (pt) * 1990-08-15 1999-01-29 British Bio Technology Processo para a preparacao de compostos que sao antagonistas do factor de activacao de plaquetas por exemplo derivados de benzimidazole e de seus intermediarios
GB9202791D0 (en) * 1992-02-11 1992-03-25 British Bio Technology Compounds
ES2087038B1 (es) * 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.

Also Published As

Publication number Publication date
AR004198A1 (es) 1998-11-04
KR970707125A (ko) 1997-12-01
ATE198751T1 (de) 2001-02-15
PT790998E (pt) 2001-04-30
WO1997009329A1 (en) 1997-03-13
MX9702919A (es) 1998-04-30
GR3035622T3 (en) 2001-06-29
DE69611598T2 (de) 2001-06-07
US5747477A (en) 1998-05-05
KR100481300B1 (ko) 2005-07-29
AU6987596A (en) 1997-03-27
BR9606628A (pt) 1997-09-30
DK0790998T3 (da) 2001-02-05
CA2204747A1 (en) 1997-03-13
ES2155621T3 (es) 2001-05-16
CA2204747C (en) 2009-05-05
NO308850B1 (no) 2000-11-06
EP0790998A1 (de) 1997-08-27
EP0790998B1 (de) 2001-01-17
JPH11501939A (ja) 1999-02-16
JP4115522B2 (ja) 2008-07-09
NO972113D0 (no) 1997-05-07
NO972113L (no) 1997-05-07

Similar Documents

Publication Publication Date Title
DE69722681D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen
ATE195527T1 (de) Neue steroidester zur behandlung von hauterkrankungen
DE69630479D1 (de) Arzneimittel zur Behandlung von entzündlichen Herzkrankheiten
DE69612649T2 (de) Indolinonverbindungen zur behandlung von krankheiten
DE69124293T2 (de) Vorrichtung zur Behandlung von Wirbelsäulenerkrankungen
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
DE69319270T2 (de) Verfahren zur Behandlung von organischen Schlämmen
DE69109583D1 (de) Verfahren zur Behandlung von entzündlichen Darmerkrankungen.
DE69611598D1 (de) Azoderivate von 5-aminosalicylsäure zur behandlung von enzündlichen darmerkrankungen
DE69634951D1 (de) Topische verwendung von betulinsäure zur behandlung bösartiger melanome
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
DE69519577D1 (de) Prednisolonmetasulfobenzoatzusammensetzung zur behandlung von entzündungserkrankung des darmes
ATE201992T1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
DE69534701D1 (de) Verfahren zur behandlung von entzündlichen gelenkerkrankungen
DE69620691T2 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
EE03437B1 (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
DE69809223D1 (de) 5-alpha-pregnan-3-beta-ol-20-one 3-sulfate für di behandlung von tumoren und zns krankheiten
DE60017174D1 (de) Rivastigmine zur behandlung von augenerkrankungen
DE60005685D1 (de) Oxazinocarbazole zur behandlung von cns-erkrankungen
ATE218866T1 (de) Kombinationstherapie zur behandlung von aids

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8327 Change in the person/name/address of the patent owner

Owner name: PALAU PHARMA,S.A., PALAU-SOLITA I PLEGAMANS, B, ES

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC